Background
==========

Graves' disease is an autoimmune thyroid disease (AITD), with a worldwide prevalence of approximately 1% \[[@b1-medscimonit-25-1439]\]. There is epidemiological evidence that genetic factors play an important role in the pathogenesis of Graves' disease \[[@b2-medscimonit-25-1439]\]. This disease shows a familial association among first-degree and second-degree relatives, known as multiplex families \[[@b3-medscimonit-25-1439],[@b4-medscimonit-25-1439]\]. The risk of Graves' disease for family members of Graves' disease patients is 15 times higher than that of the general population \[[@b5-medscimonit-25-1439]\]. The concordance rate for the prevalence of Graves' in monozygotic twins is significantly greater than that of dizygotic twins \[[@b6-medscimonit-25-1439]\]. The presence of circulating anti-thyroid antibodies occurs in between 50--70% of family members patients with Graves' disease \[[@b7-medscimonit-25-1439]\]. However, the concordance rate of Graves' disease prevalence for monozygotic twins (36%) is less than 100%, suggesting that other parameters, such as environmental factors, can impact the occurrence of Graves' disease, which creates a further challenge to studies on the genetic associations. Also, Graves' disease does not follow classical Mendelian inheritance, which indicates that there might be multiple genes involved in the pathogenesis \[[@b8-medscimonit-25-1439]\].

Previously published studies have investigated the genetic causes of Graves' disease, but the genetic mechanisms underlying the pathogenesis of this condition remain poorly understood \[[@b9-medscimonit-25-1439]--[@b11-medscimonit-25-1439]\]. Early family studies that investigated multiplex families with Graves' disease and association analysis studies have shown that Graves' disease is associated with the expression of several genes with varied penetrance rates, as well as gene interactions and gene and environment interactions.

Family multiplex pedigree linkage analysis is based on identifying characteristics that are segregated with both genes and traits. Genetic marker analysis can be performed to indirectly locate disease-associated genes by observing the co-segregation between gene markers and sequence data. Recent studies have shown that on chromosome 5, the 5q32--33.1 region is a major susceptibility locus for Graves' disease in East Asian populations \[[@b12-medscimonit-25-1439],[@b13-medscimonit-25-1439]\]. Also, Graves' disease susceptibility regions were identified by genetic markers and genome-wide scanning, including 6p, 7q, 8q, 10q, and 12q \[[@b12-medscimonit-25-1439],[@b13-medscimonit-25-1439]\]. However, linkage analysis does not identify the complex gene polymorphisms and the precise positioning of Graves' disease genes, which means that it is not possible to comprehensively analyze all the genetic associations in Graves' disease. However, when related genes are identified and their functions are known, candidate gene association based on linkage analysis can identify the role of specific genes in Graves' disease. When combined with haplotype evaluation, linkage analysis provides a promising approach to begin to identify disease-related susceptibility genes \[[@b14-medscimonit-25-1439]\].

A haplotype refers to a group of related single nucleotide polymorphism (SNP) alleles located in a region of the same chromosome. After many generations, with repeated chromosome recombination events, the original arrangement of ancestral chromosome fragments will change, but the unchanged gene fragments following recombination, and separated by recombination regions, constitute a haplotype \[[@b14-medscimonit-25-1439]\]. Identifying the haplotype domain structure in the chromosome provides a convenient way to assess disease susceptibility genes. A tag SNP is a representative SNP that is found in a genome region with high linkage disequilibrium, and a group of SNPs forms the haplotype. A high degree of linkage disequilibrium in the haplotype domain only includes a few common haplotypes, but by detecting a small number of tag SNPs, the composition of the common haplotype in the region can be identified. This analytical approach is more economical and effective when compared with mass screening for every polymorphic locus.

Currently, several genes have been identified in patients with Graves' disease and have been studied in different ethnicities, including HLA-associated genes, CD40, CTLA-4, PTPN22, FCRL3, Thyroglobulin, TSHR and FOXP3 \[[@b9-medscimonit-25-1439],[@b15-medscimonit-25-1439]--[@b17-medscimonit-25-1439]\]. Relatively few studies have been undertaken on the 5q31--33 region, a major susceptibility locus of Graves' disease in East Asian populations. The present study investigated 80 Graves' disease multiplex families in the Chinese Han population and used tag SNPs to assess Graves' disease susceptibility genes in these individuals. This study aimed to investigate the susceptibility to Graves's disease and the association with the 5q32--33.1 region on chromosome 5 in a Chinese Han population.

Material and Methods
====================

Selection criteria for the Graves' disease family pedigrees
-----------------------------------------------------------

The study was conducted at the First Affiliated Hospital of China Medical University. This study was approved by the Ethics Committee of the Fourth Affiliated Hospital of China. Medical University and was conducted according to the Declaration of Helsinki. Signed informed consent was obtained from each study participant.

The selection of study participants included multiplex families, consisting of individuals with Graves's disease who had first-degree and second-degree relatives with Graves' disease. All study participants were of Chinese Han ethnicity. The lowest standard for selecting pedigrees was at least four first-degree relatives, including the proband. Because age impacts the disease penetrance affected first-degree relatives \<18 years of age were not included in the study. Graves' disease was diagnosed according to criteria that included a clinical diagnosis of hyperthyroidism, a diffuse goiter, eye signs that included exophthalmos, a positive thyroid stimulating hormone (TSH) receptor antibody (TRab) test, and a diffusely increased thyroid uptake of ^123^I by the radioactive iodine uptake (RAIU) test. At least three of these diagnostic criteria were required for inclusion in the study as a case of Graves' disease.

Eighty Graves' disease multiplex families of Han ethnicity included 478 study participants, 201 patients with Graves' disease and an average of six individuals per pedigree or family. The study participants were recruited from ten cities in Liaoning Province. Pedigrees with one, two, three, four, and five first-degree relatives suffering from the disease were 20 (25%), 37 (46%), 16 (20%), five (6%) and two (3%), respectively. The 201 cases of Graves' disease included 45 men and 156 women, with a mean age of 43.72±14.31 years, and a male to female ratio of 1: 3. First-degree and second-degree relatives of the patients with Graves' disease included 277 cases, 136 men and 141 women, with a mean age of 48.95±16.98 years.

Microsatellite detection
------------------------

From the database of published genome-wide screening microsatellite markers (STRs), within the genetic distance of about 8 cM (centimorgan) of chromosome 5 at the 5q32--33.1 region (between D5S436--D5S434), eight microsatellite markers with \>70% heterozygosity, including D5S2017, D5S1480, D5S436, D5S2847, D5S2090, D5S434, D5S413, and D5S2014, were selected.

Microsatellite locus detection
------------------------------

Analysis of published polymerase chain reaction (PCR) primers ([Supplementary Table 1](#s1-medscimonit-25-1439){ref-type="supplementary-material"}), identified PCR products that were used for electrophoresis with the default program on the automated GeneScan ABI PRISM™ 3730xl DNA Analyzer (ThermoFisher Scientific, Waltham, MA, USA). The sizes of the detected fragments were analyzed using GeneMapper software version 4.0 (ThermoFisher Scientific, Waltham, MA, USA).

Construction of the domain structure of the haplotype of chromosome 5 at the 5q32--33.1 region
----------------------------------------------------------------------------------------------

In the Graves' disease linkage region (D5S1480--D5S2014), 74 single nucleotide polymorphisms (SNPs) with more than 20% low-frequency alleles located around the gene coding region were selected using the dbSNP database published by the National Center for Biotechnology Information (NCBI). Except for the fourteenth and fiftieth SNPs, the remaining detected SNPs were in Hardy-Weinberg equilibrium, indicating that samples had good comparability. No information was recorded for the fourteenth and fiftieth SNPs in subsequent analysis.

Forty-eight probands were selected from the Graves' disease multiplex pedigrees that were used for gene positioning for analysis of the selected SNPs using the pyrosequencing method \[[@b18-medscimonit-25-1439],[@b19-medscimonit-25-1439]\]. SNP genotype information of 45 normal Chinese Han individuals was obtained from the international HapMap database ([www.hapmap.org](www.hapmap.org)) \[[@b20-medscimonit-25-1439],[@b21-medscimonit-25-1439]\].

Detection of tag SNPs of chromosome 5 at the 5q32--33.1 region in the Chinese Han population and their association with Graves' disease
---------------------------------------------------------------------------------------------------------------------------------------

In the constructed 5q32--33.1 haplotype, the sixth and eighth haplotypes (block 6 and block 8) spanned the JAKMIP2 and SCGB3A2 genes with three and five tag SNPs, respectively. Detection was performed using the TaqMan genotyping method on the eight SNP *loci* ([Supplementary Table 2](#s2-medscimonit-25-1439){ref-type="supplementary-material"}) for all members of the 80 Graves' disease multiplex pedigrees \[[@b22-medscimonit-25-1439],[@b23-medscimonit-25-1439]\].

Statistical analysis
--------------------

GeneHunter software version 2.0 was used in linkage analysis to assess two-point HLOD scores, multipoint HLOD scores, and multipoint nonparametric linkage (NPL) scores for each microsatellite. Correlation analysis between single SNPs was performed using the chi-squared (χ^2^) test or Fisher's exact test with SPSS version 11.5. Construction of the haplotype domain structure was performed using Haploview version 4.2 software (*[www.broadinstitute.org/haploview](www.broadinstitute.org/haploview)*) \[[@b24-medscimonit-25-1439]\]. The minimum value of the minor allele frequency (MAF) was set to 0.05, and tag SNPs were selected with r^2^ \>0.8 between the SNPs. A transmission disequilibrium test (TDT) was conducted based on pedigree samples \[[@b25-medscimonit-25-1439],[@b26-medscimonit-25-1439]\]. A P-value \<0.05 was considered to be statistically significant.

Results
=======

Linkage analysis between chromosome 5 at the 5q32--33.1 region and Graves' disease in the Chinese Han population
----------------------------------------------------------------------------------------------------------------

Graves' disease is a complex disease with significant genetic heterogeneity; however, its inheritance pattern and penetrance are unclear \[[@b27-medscimonit-25-1439]\]. The linkage analysis results by the two-point parameter method are shown in [Supplementary Table 3](#s3-medscimonit-25-1439){ref-type="supplementary-material"}. In recessive inheritance with the 30--100% penetrance model, the selected screening microsatellite markers (STRs) reached peak two-point heterogeneity logarithm of the odds (HLOD) scores. Except for the two-point HLOD score of D5S2017, which was 1.74 (α=0.21), the HLOD scores of other *loci* were \>2, and D5S2090 showed the highest HLOD score of 4.29 (α=0.42). An HLOD score of \>1.9 supported linkage, while a HLOD score \>3.3 indicated significant linkage \[[@b28-medscimonit-25-1439],[@b29-medscimonit-25-1439]\]. These results indicated that the chromosome 5 region D5S1480--D5S2014 was significantly linked with Graves' disease.

In linkage analysis by the multipoint parameter method ([Supplementary Table 4](#s4-medscimonit-25-1439){ref-type="supplementary-material"}), the results showed that in the selected STRs, except for D5S2017 whose highest multipoint HLOD score was 1.53 (α=0.19), the highest multipoint HLOD scores of the remaining 7 STRs were above 2. The highest multipoint HLOD score for D5S2014 was 4.01 (α=0.34). In linkage analysis of a single positive linkage pedigree, multipoint HLOD scores were between 0.1--0.2. This finding supported that the D5S1480--D5S2014 region on chromosome 5 was significantly linked with Graves' disease.

Linkage analysis results by the multipoint nonparametric method of selected STRs are shown in [Supplementary Table 5](#s5-medscimonit-25-1439){ref-type="supplementary-material"}. Except for the nonparametric linkage (NPL) score of 1.93 for D5S2017 (P=0.014), NPL scores for the remaining 7 STRs were \>2 and the maximum NPL score was 3.12 (P\<0.001), which occurred at D5S2014. This result also suggested that this region was significantly associated with Graves' disease.

Single nucleotide polymorphism (SNP) analysis of chromosome 5 at the 5q32--33.1 region and construction of the haplotype domain structure
-----------------------------------------------------------------------------------------------------------------------------------------

Seventy-two SNPs located around the gene coding region were selected from the Graves' disease linkage region (D5S1480--D5S2014). There were statistical differences in allele distribution of the SNP71 rs3843496 locus and the remaining five *loci*, between Graves' disease patients and normal individuals (SNP71 rs3843496, P=0.0002) (SNP2 rs11435, SNP36 rs1383167, SNP60 rs6866266, SNP62 rs12653715, and SNP67 rs11948325, P\<0.05). These data are summarized in [Supplementary Table 6](#s6-medscimonit-25-1439){ref-type="supplementary-material"}.

The Haploview software was used to construct the haplotype domain structure based on PyroSequencing and HapMap data ([Figure 1](#f1-medscimonit-25-1439){ref-type="fig"}). The color shades of squares in the figure indicate the linkage disequilibrium (LD) index among SNPs, and the greater the score, the darker the square and the higher the LD index. The specific chromosome region (D5S1480--D5S2014) in the Chinese Han population consisted of eight haplotype domains. The haplotype domain structures were determined by a few representative tag SNPs. The hotspot regions for recombination were within various haplotypes.

Differences in haplotype distribution between patients with Graves' disease and normal individuals
--------------------------------------------------------------------------------------------------

A further comparison was undertaken of the distribution of major haplotypes of the eight haplotype domain structures found in chromosome 5 at the 5q32--33.1 region, between patients with Graves' disease and normal individuals. As shown in [Table 1](#t1-medscimonit-25-1439){ref-type="table"}, the proportions of AGCGTC and AACCTC haplotypes in block 6 between patients with Graves' disease and normal individuals were 19.3: 76.7; 34.5: 55.5; and 34.6: 61.4;19.5: 70.5 respectively, with a statistically significant difference (P=0.0064 and P=0.0309, respectively). The proportions of GGCCT haplotype in block 8 between patients with Graves' disease and normal individuals were 79.0: 17.0 and 61.5: 28.5, respectively, with statistical significance (P=0.0274). Single *loci* with significant differences, including SNP60, SNP60rs6866266, and SNP62 rs12653715, were located in block 6. SNP71 rs3843496 was located in block 8. Therefore, the study focused on the relationship between this region of chromosome 5 and Graves' disease.

The relationship between target SNPs and Graves' disease
--------------------------------------------------------

Region 6 and region 8 associated with Graves' disease were selected from the constructed 5q32--33.1 haplotype domain structures and the tag SNPs were selected as target SNPs. Block 6 and block 8 (the sixth and eighth haplotypes) spanned the JAKMIP2 and SCGB3A2 genes with three and five tag SNPs, respectively ([Figure 2](#f2-medscimonit-25-1439){ref-type="fig"}). Genotype distribution for each SNP locus followed the Hardy-Weinberg equilibrium. The distribution of each SNP allele and genotype in the case-control group is shown in [Table 2](#t2-medscimonit-25-1439){ref-type="table"}. The G allele of the rs12653715 locus was significantly associated with Graves' disease (P=0.106). The genotype distribution of the locus in the case-control group was different (P=0.117), and further analysis showed that individuals who were GG homozygous at the rs12653715 locus were more likely to suffer from Graves' disease compared with individuals who were with GC heterozygous and CC homozygous (GG *vs.* GC + CC, OR=1.46; 95% CI, 1.011--2.108; P=0.043).

Transmission disequilibrium testing of the JAKMIP2 and SCGB3A1 genes
--------------------------------------------------------------------

As shown in [Table 3](#t3-medscimonit-25-1439){ref-type="table"}, *loci* with transmission disequilibrium were SNP62 (rs12653715) and SNP63 (rs12652081) in the JAKMIP2 gene. The SNP62 and SNP63 *loci* in the JAKMIP2 gene were associated with susceptibility to Graves' disease (all pedigrees, P=0.0416 and P=0.0234; positive linkage pedigrees, P=0.0285 and P=0.0005). Also, transmission of alleles G and C from heterozygous parents to their children with Graves' disease was found. SNPs in the SCGB3A2 gene showed no dominant transmission from heterozygous parents to the affected offspring (all P\>0.05).

As shown in [Table 4](#t4-medscimonit-25-1439){ref-type="table"}, in all pedigrees, including positive linkage pedigrees, there was transmission disequilibrium in the GC haplotype. The G allele at the SNP62 (rs12653715) locus and C allele at the SNP63 (rs12652081) locus (P=0.0128 and P=0.0005) were found in the JAKMIP2 gene. This haplotype was termed 'JAKMIP2-1,' which might represent a Graves' disease high-risk haplotype. Also, in positive linkage pedigrees, the other two haplotypes with the T allele, including the SNP63 locus, also showed transmission disequilibrium (P=0.0489 and P=0282). However, these alleles were rarely passed onto the offspring of heterozygous parents with Graves' disease due to the protective effects of these haplotypes. Several haplotypes in the SCGB3A2 gene did not reveal dominant transmission from heterozygous parents to affected offspring.

Discussion
==========

Graves' disease is a common organ-specific autoimmune disease that involves the thyroid gland. Recent studies have shown that genetic factors are an important cause of the familial association with Graves' disease. This study used pedigree case-control testing with the two-point parametric testing, multi-point parametric testing, and multi-point nonparametric linkage (NPL) methods to perform linkage analysis with Graves' disease on chromosome 5 at the 5q32--33.1 region (D5S2017--D5S2014). Also, the D5S1480--D5S2014 region of chromosome 5 was associated with Graves' disease. A recently published study using linkage analysis with parametric linkage and non-parametric linkage (NPL) methods demonstrated that D5S436 and D5S2090 of the 5q31 region of chromosome 5 were significantly associated with Graves' disease, indicating that one of the major susceptibility *loci* of Graves' disease is located in the 5q31 region, with genetic heterogeneity \[[@b12-medscimonit-25-1439]\]. Further studies have also shown that the 5q31 region, as well as 5q32--33.1 region on chromosome 5, were Graves' disease susceptibility *loci* in an Asian population \[[@b13-medscimonit-25-1439],[@b30-medscimonit-25-1439]\]. However, inconsistent findings have been reported for Caucasian populations \[[@b31-medscimonit-25-1439]--[@b33-medscimonit-25-1439]\], possibly due differences in the phenotype and genotype of Graves' disease in different ethnic groups. In line with previous studies in East Asian patients with Graves' disease, the present study confirmed that on chromosome 5, the 5q32--33.1 region was a Graves' disease linkage region, suggesting that East Asians may have the same Graves' disease susceptibility *loci*.

The complex single nucleotide polymorphisms (SNPs) in this study was a third-generation marker and involved in all known SNPs of the genes of the study subject genes in combination with common haplotypes. The efficiency of this study was largely improved by the use of tag SNPs, avoiding sequencing problems for multiple SNPs. A parametric method-based linkage analysis was used for the selected eight microsatellite markers in chromosome 5 at the 5q32--33.1 region (D5S2017--D5S2014) and derived two-point HLOD scores with different inheritance modes (dominant, recessive) and penetrance rates (30%, 60%, 90%, and 100%). The maximum two-point HLOD score was obtained for each screening microsatellite marker (STR) when θ was equal to 0; α was the proportion of positive linkage pedigree (HLOD score \>+0.1). The two-stage method established by Thomas et al. was applied to construct the haplotype domain structure of chromosome 5 at the 5q32--33.1 region in the Chinese Han population, and determine representative tag single nucleotide polymorphisms (SNPs) for linkage analysis of Graves' disease susceptibility genes.

Block 6 was located in JAKMIP2, and there was linkage disequilibrium (LD) in the SNP61 (rs7713010 C/T), SNP62 (rs12653715 G/C), and SNP63 (rs12653081 T/C) *loci* of this haplotype. The transmission disequilibrium test (TDT) is a method that uses pedigree samples to detect the associations of genetic *loci* with diseases. In a random population, since pedigree samples were directly used for genome-wide scanning, the major susceptibility of Graves' disease members in most of the pedigrees should be around chromosome 5 at the 5q32--33.1 region. It is better to exclude the influence of common genetic heterogeneity factors in multiple genetic diseases. If some genetic *loci* (microsatellite or SNP *loci*) are associated with the prevalence of a disease, the probability of passing this locus from heterozygous parents to the affected offspring in the pedigree should be significantly greater than the odds of passing them to the unaffected descendants. This study included 80 Graves' disease multiplex pedigrees (478 members) and 24 positive linkage pedigrees (LOD score \>0.1 in linkage analysis), respectively, to perform transmission disequilibrium test for each SNP locus located in the JAKMIP2 and SCGB3A2 genes and haplotype. The results showed that the G allele of the SNP62 locus (P=0.0416) and C allele of the SNP63 locus (P=0.0005) had dominant transmission from heterozygous parents to the affected offspring. Also, the JAKMIP2-1 haplotype determined by SNP62 G+ SNP63 C also had significant dominant transmission (P=0.0005). Alleles and genotypes in other *loci* had similar distribution patterns in case and control groups, and the difference in distribution frequencies did not reach statistical significance. The above findings indicated that the JAKMIP2 gene may be associated with Graves' disease prevalence.

The Janus kinase and microtubule interacting protein 2 (JAKMIP2) gene is also known as neuroendocrine long coiled-coil protein-1 (NECC1) gene and is located in the 5q32 region of the human chromosome, containing 21 exons with a full length of 199kb. The JAKMIP2 protein is preferentially expressed in the neuroendocrine tissues of vertebrates, including in the central nervous system, the pituitary, the adrenal gland, and the testes, and has been identified as a component of the Golgi matrix \[[@b34-medscimonit-25-1439]--[@b36-medscimonit-25-1439]\]. Currently, limited information is available regarding the function of JAKMIP2. Cruz-Garcia and colleagues have reported an inverse relationship between JAKMIP2 expression and hormone secretion in pituitary melanotropes in frogs \[[@b37-medscimonit-25-1439]\], and have further demonstrated that JAKMIP2 acts as a negative modulator of the regulated secretory pathway in PC12 cells *in vitro* \[[@b38-medscimonit-25-1439]\]. The potential roles of JAKMIP2 in thyroid hormone regulation and in the etiology of Graves' disease requires further investigation.

Recent studies on gene structure and function have shown that introns can be self-excising, and regulate gene expression \[[@b39-medscimonit-25-1439],[@b40-medscimonit-25-1439]\]. SNPs located in the exon-exon junction region can affect mRNA excision by promoting the partial deletion of the exon sequence or maintain the intron sequence uncut, leading to disease development. Mutations in the middle of an intron can cause disease by activating the recessive cleavage site that affects mRNA excision \[[@b39-medscimonit-25-1439]\]. In this study, SNP62 and SNP63 were located in the intron of the JAKMIP2 gene, but how introns affect JAKMIP2 protein function requires further study.

The secretoglobin family 3A, member 2 (SCGB3A2) gene, also known as the uteroglobin-related protein 1(UGRP1) gene, is a member of the immunoglobulin superfamily \[[@b41-medscimonit-25-1439]\]. The SCGB3A2 gene is found on human chromosome 5 at the 5q33.1 region, with a length of 2.9 kb, and has three exons and twelve introns. SCGB3A2 is mainly expressed in lung tissues but is also expressed in thyroid tissues \[[@b42-medscimonit-25-1439]\]. The SCGB3A2 secreted protein binds to specific receptors on the surface of target cells. In previous studies, SCGB3A2 has been reported to be associated with Graves' disease in two Caucasian populations and one Han population \[[@b32-medscimonit-25-1439],[@b33-medscimonit-25-1439],[@b43-medscimonit-25-1439]\]. The results from the present study showed that the allele, the genotype, and the haplotype of SCGB3A2 and each SNP locus had similar distributions in the cases of Graves' disease and control groups, and the difference between them was not statistically significant. Also, there was no dominant transmission from heterozygous parents to the affected offspring. Therefore, in the assessed Chinese Han pedigrees, SCGB3A2 may not be a major susceptibility gene for Graves' disease.

This study analyzed the association of the JAKMIP2 gene and Graves' disease using comparative tests of pedigree cases and found that JAKMIP2 might be a genetic risk factor for Graves' disease. However, this study had several limitations. Although 80 Graves' disease multiplex pedigrees or families were recruited, the sample size was relatively small. The results cannot explain the role of JAKMIP2 gene abnormalities in the pathogenesis of Graves' disease. Also, this study only showed that the expression of the JAKMIP2 gene might be a molecular marker for the risk of developing Graves' disease, but whether or not the JAKMIP2 gene is associated with the clinical parameters of Graves' disease requires clarification and the specific mechanism by which the JAKMIP2 gene increases the risk of Graves' disease remains to be investigated. Further genetic, epidemiologic, and functional studies are required to elucidate the relationship between JAKMIP2 gene polymorphisms, including the haplotype JAKMIP2-1, and Graves' disease.

Conclusions
===========

This study showed that the expression of the JAKMIP2 gene polymorphisms was associated with the presence of Graves' disease in a Chinese Han population. The JAKMIP2-1 haplotype was identified as being particularly significant. The mechanisms underlying this gene association in the Chinese Han population and in other populations requires further study.

Supplementary Tables
====================

###### 

Primer sequences of microsatellites.

  STRs                   Forward                           Reverse
  ---------------------- --------------------------------- ---------------------------------
  D5S1072                5′-GAGTCCTCTCACTGATATTTTTGTA-3′   5′-GTCTATCCTTCCAGATGGTTC-3′
  D5S1082                5′-TTGGGAAGAATAGCTTTCCC-3′        5′-TTCTAGCTTCCCCCTATGCT-3′
  D5S638                 5′-TATGTGCCAGGCATTACGCT-3′        5′-GTCTCCACCCACAGCAGG-3′
  D5S2748 (GATA139B09)   5′-GACTTCTCCACCCCCATAAC-3′        5′-TTAGTCAGGTTCTCCAGAGAGG-3′
  D5S2009                5′-CATGGGCATGTTTCAAAAT-3′         5′-AGTACCTCCTTAGTAACTCTGGGC-3′
  D5S343                 5′-CTTGAAATGTTCCCAACACA-3′        5′-TGCACAGATGAGGAAACTGA-3′
  D5S324                 5′-AGTCACCTTCTCTGTCTCCA-3′        5′-AGGCCTCATTCAAAATCTGT-3′
  D5S2034                5′-AGCTACTACCAGCAGCATTC-3′        5′-CTACATTATTATTATTGTGTGTCCG-3′

Primer sequences were from UniSTS database.

###### 

Information on target SNPs.

  SNPs No.   Name         Position in UCSC (bp)   Alleles   Genes     *Loci*
  ---------- ------------ ----------------------- --------- --------- --------------
  SNP61      rs7713010    147724712               C/T       JAKMIP2   Intron1
  SNP62      rs12653715   147732794               C/G       JAKMIP2   Intron1
  SNP63      rs12652081   147737372               T/C       JAKMIP2   Intron1
  SNP68      rs6882292    147877993               G/A       SCGB3A2   Near-gene-5′
  SNP69      rs1368408    147878599               G/A       SCGB3A2   Near-gene-5′
  SNP70      rs3910207    1477881921              C/T       SCGB3A2   Intron1
  SNP71      rs3843496    147882249               C/T       SCGB3A2   Near-gene-3′
  SNP72      rs3910183    1477882352              T/G       SCGB3A2   Near-gene-3′

The positions of the SNPs were based on UCSC Genome Browser on Human Dec. 2013 (GRCh38/hg38) assembly.

###### 

Microsatellite-marked two-point HLOD scores of different penetrance rates of various genetic modes.

  Microsatellite   HLOD(α) of each penetrance of dominant inheritance   HLOD (LO of each penetrance of recessive inheritance                                                                         
  ---------------- ---------------------------------------------------- ------------------------------------------------------ ------------- ------------- ------------- ------------- ------------- -------------
  D5S2017          0.25 (0.18)                                          0.15 (0.12)                                            0.06 (0.05)   0.00 (0.01)   0.64 (0.15)   0.99 (0.18)   1.47 (0.20)   1.74 (0.21)
  D5S1480          1.56 (0.43)                                          1.43 (0.37)                                            0.70 (0.20)   0.04 (0.04)   2.05 (0.30)   2.54 (0.32)   2.83 (0.30)   2.79 (0.27)
  D5S436           2.00 (0.47)                                          2.03 (0.43)                                            1.01 (0.23)   0.04 (0.03)   2.25 (0.28)   2.69 (0.29)   2.94 (0.27)   2.66 (0.23)
  D5S2847          0.95 (0.38)                                          0.88 (0.32)                                            0.51 (0.18)   0.00 (0.00)   2.79 (0.36)   3.27 (0.37)   3.78 (0.35)   3.79 (0.33)
  D5S2090          1.79 (0.48)                                          1.65 (0.42)                                            0.64 (0.20)   0.06 (0.06)   3.34 (0.44)   2.46 (0.29)   4.29 (0.42)   4.10 (0.38)
  D5S434           0.43 (0.24)                                          0.28 (0.17)                                            0.07 (0.07)   0.00 (0.00)   2.07 (0.28)   3.83 (1)      2.90 (0.27)   2.80 (0.25)
  D5S413           1.17 (0.43)                                          0.93 (0.35)                                            0.23 (0.12)   0.00 (0.00)   2.41 (0.33)   3.05 (0.36)   3.79 (0.37)   3.69 (0.29)
  D5S2014          2.70 (0.52)                                          2.13 (0.41)                                            0.73 (0.17)   0.02 (0.02)   3.30 (0.35)   3.64 (0.36)   3.56 (0.32)   3.09 (0.26)

α, ratio of positive linkage pedigrees. Blue, HLOD \>+1.9; Red, HLOD \>+3.3.

###### 

Microsatellite-marked maximum multi-point HLOD scores for different penetrance rates.

  Microsatellite   Genetic distance (cm)   Multi-point HLOD value (oi)   Penetrance/genetic mode
  ---------------- ----------------------- ----------------------------- ----------------------------
  D5S2017          145.21                  1.53 (0.19)                   100%/recessive inheritance
  D5S1480          147.49                  3.06 (0.26)                   90%/recessive inheritance
  D5S436           147.49                  3.53 (0.27)                   90%/recessive inheritance
  D5S2847          149.48                  3.60 (0.24)                   100%/recessive inheritance
  D5S2090          150.34                  3.59 (0.24)                   100%/recessive inheritance
  D5S434           150.34                  3.63 (0.27)                   100%/recessive inheritance
  D5S413           150.34                  3.62 (0.27)                   90%/recessive inheritance
  D5S2014          153.17                  4.01 (0.34)                   60%/recessive inheritance

Genetic distance was selected from Marshfield database; i, average distance between genders; α, ratio of positive linkage pedigrees. Blue, HLOD \>+1.9; Red, HLOD \>+3.3.

###### 

Multipoint NPL scores for microsatellites in chromosome 5q32--33.1.

  Microsatellite   Genetic distance (cm)   NPL-score   P-value                                                          Information
  ---------------- ----------------------- ----------- ---------------------------------------------------------------- -------------
  D5S2017          145.21                  1.92        0.014[\*](#tfn14-medscimonit-25-1439){ref-type="table-fn"}       0.89
  D5S1480          147.49                  2.13        0.008[\*\*](#tfn15-medscimonit-25-1439){ref-type="table-fn"}     0.91
  D5S436           147.49                  2.30        0.005[\*\*](#tfn15-medscimonit-25-1439){ref-type="table-fn"}     0.90
  D5S2847          149.48                  2.03        0.011[\*](#tfn14-medscimonit-25-1439){ref-type="table-fn"}       0.93
  D5S2090          150.34                  2.03        0.011[\*](#tfn14-medscimonit-25-1439){ref-type="table-fn"}       0.94
  D5S434           150.34                  2.10        0.009[\*\*](#tfn15-medscimonit-25-1439){ref-type="table-fn"}     0.94
  D5S413           150.34                  2.78        0.001[\*\*](#tfn15-medscimonit-25-1439){ref-type="table-fn"}     0.92
  D5S2014          153.17                  3.12        \<0.001[\*\*](#tfn15-medscimonit-25-1439){ref-type="table-fn"}   0.91

Genetic distance was selected from the Marshfield database, i, average distance between genders.

*P*\<0.05;

*P*\<0.01.

###### 

Results of association analysis between SNPs and GD.

  No.   SNP          Allele   Case: Control ratio   Chi Square   P value
  ----- ------------ -------- --------------------- ------------ ---------------------------------------------------------------
  1     rs443033     T        45: 43, 36: 54        2.225        0.1358
  2     rs11435      G        72: 22, 56: 34        4.487        0.0342[\*](#tfn16-medscimonit-25-1439){ref-type="table-fn"}
  3     rs6877277    T        81: 15, 75: 15        0.037        0.8469
  4     rs11167937   C        82: 10, 75: 15        1.290        0.2560
  5     rs7718587    T        35: 57, 33: 57        0.037        0.8478
  6     rs319227     G        71: 25, 66: 24        0.009        0.923
  7     rs186459     T        26: 70, 24: 66        0.004        0.9489
  8     rs1835950    T        34: 60, 31: 59        0.06         0.8066
  9     rs319217     A        26: 70, 24: 66        0.004        0.9489
  10    rs2082405    A        66: 26, 63: 27        0.067        0.7963
  11    rs319204     A        26: 70, 23: 65        0.021        0.8846
  12    rs319193     G        69: 27, 60: 30        0.593        0.4413
  13    rs319189     A        69: 27, 60: 30        0.593        0.4413
  15    rs586362     A        68: 26, 60: 30        0.699        0.4031
  16    rs675846     A        67: 27, 60: 30        0.457        0.4990
  17    rs577197     G        70: 26, 63: 27        0.194        0.6597
  18    rs167634     T        68: 26, 64: 26        0.034        0.8531
  19    rs319166     C        70: 26, 63: 27        0.194        0.6597
  20    rs178549     A        70: 26, 63: 27        0.194        0.6597
  21    rs319162     T        68: 28, 57: 33        1.186        0.2762
  22    rs319161     G        71: 25, 63: 27        0.361        0.5478
  23    rs10068414   A        40: 54, 30: 60        1.658        0.1978
  24    rs589793     C        69: 27, 64: 26        0.013        0.9082
  25    rs1864982    C        69: 25, 64: 26        0.121        0.7283
  26    rs2915842    A        27: 63, 25: 65        0.108        0.7422
  27    rs1126057    G        24: 72, 20: 70        0.198        0.6560
  28    rs6580445    C        24: 72, 20: 70        0.198        0.6560
  29    rs2017562    A        21: 75, 18: 72        0.099        0.7536
  30    rs1842346    T        20: 72, 18: 72        0.083        0.7729
  31    rs4705449    T        67: 27, 61: 29        0.266        0.6061
  32    rs11953078   C        65: 31, 49: 41        3.445        0.0635
  33    rs11167951   T        67: 27, 54: 36        2.597        0.1071
  34    rs1383168    G        27: 67, 16: 74        3.076        0.0795
  35    rs4552686    A        66: 28, 54: 36        2.114        0.1460
  36    rs1383167    A        28: 68, 15: 75        4.084        0.0433[\*](#tfn16-medscimonit-25-1439){ref-type="table-fn"}
  37    rs7713487    A        37: 57, 29: 59        0.807        0.3689
  38    rs9325031    A        25: 71, 16: 74        1.846        0.1742
  39    rs9325032    C        41: 51, 33: 57        1.176        0.2781
  40    rs6880660    A        24: 68, 15: 75        2.398        0.1215
  41    rs1480157    G        65: 31, 50: 40        2.907        0.0882
  42    rs1480155    C        23: 73, 15: 73        1.339        0.2472
  43    rs6580448    T        43: 49, 40: 50        0.097        0.7560
  44    rs1480152    G        54: 42, 40: 50        2.59         0.1075
  45    rs1480149    G        48: 46, 38: 52        1.444        0.2295
  46    rs1480150    T        52: 42, 41: 49        1.753        0.1854
  47    rs1156700    A        50: 42, 41: 49        1.407        0.2356
  48    rs1480151    T        49: 43, 41: 49        1.081        0.2986
  49    rs31039      T        62: 32, 56: 34        0.279        0.5974
  51    rs7713582    A        88: 8, 78: 12         1.210        0.2713
  52    rs4705185    T        87: 9, 78: 12         0.727        0.3940
  53    rs6892958    T        41: 55, 38: 52        0.004        0.9466
  54    rs4705041    A        88: 8, 76: 12         1.333        0.2483
  56    rs10051794   T        57: 39, 52: 38        0.049        0.8251
  57    rs6580495    G        89: 7, 78: 10         0.908        0.3407
  58    rs1432827    T        42: 50, 41: 49        0.001        0.9896
  59    rs2288825    G        39: 55, 33: 57        0.449        0.5028
  60    rs6866266    A        38: 58, 21: 67        5.208        0.0225[\*](#tfn16-medscimonit-25-1439){ref-type="table-fn"}
  61    rs7713010    T        14: 82, 13: 77        0.001        0.9786
  62    rs12653715   C        38: 58, 21: 69        5.663        0.0173[\*](#tfn16-medscimonit-25-1439){ref-type="table-fn"}
  63    rs12652081   C        41: 55, 35: 55        0.280        0.5964
  64    rs6895278    C        74: 22, 68: 22        0.060        0.8064
  65    rs9688059    C        47: 49, 33: 57        2.863        0.0906
  66    rs7719181    A        52: 40, 40: 46        1.784        0.1817
  67    rs11948325   G        49: 47, 33: 57        3.894        0.0485[\*](#tfn16-medscimonit-25-1439){ref-type="table-fn"}
  68    rs6882292    G        92: 4, 84: 6          0.571        0.4500
  69    rs1368408    G        80: 16, 70: 20        0.919        0.3379
  70    rs3910207    C        88: 8, 73: 11         1.076        0.2996
  71    rs3843496    C        87: 9, 62: 28         13.772       0.0002[\*\*](#tfn17-medscimonit-25-1439){ref-type="table-fn"}
  72    rs3910183    T        88: 8, 79: 11         0.766        0.3815
  73    rs7722926    T        74: 22, 63: 27        1.201        0.2731
  74    rs2250145    A        67: 29, 56: 34        1.188        0.2757

P\<0.05;

P\<0.01.
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![Haplotype structure in Chinese Han individuals and the main haplotype structure of the chromosome 5q31 region.](medscimonit-25-1439-g001){#f1-medscimonit-25-1439}

![Locations of target single nucleotide polymorphisms (SNPs) in the corresponding genes.](medscimonit-25-1439-g002){#f2-medscimonit-25-1439}

###### 

Distribution of main haplotypes in each haplotype domain structure between GD cases and controls.

  Haplotype               Frequency   Case: Control ratio      Chi square   *P* value
  ----------------------- ----------- ------------------------ ------------ --------------------------------------------------------------
  Block 1                                                                   
   TGCCGAGGAAAGTCATGACC   0.345       35.2: 60.8, 29.0: 61.0   0.415        0.5194
   CGCTGAGGAAAGCCAGGGCA   0.247       22.0: 74.0, 23.9: 66.1   0.340        0.5599
   CTTCAGAATGGATTGTAGTC   0.223       20.6: 75.4, 21.0: 69.0   0.096        0.7561
  Block 2                                                                   
   TTCCTTCAGGG            0.328       26.0: 70.0, 35.0: 55.0   2.939        0.0865
   TTCCTCTGAAG            0.22        26.0: 70.0, 15.0: 75.0   2.934        0.0867
   GCATCCTAAGA            0.181       17.9: 78.1, 15.8: 74.2   0.041        0.8388
  Block 3                                                                   
   CTCT                   0.374       30.7: 65.3, 38.9: 51.1   2.467        0.1163
   CTCG                   0.218       22.3: 73.7, 18.1: 71.9   0.263        0.6082
   ACAG                   0.215       25.0: 71.0, 15.0: 75.0   2.406        0.1209
   CCCG                   0.18        17.7: 78.3, 15.9: 74.1   0.019        0.8892
  Block 4                                                                   
   AACGG                  0.489       41.0: 53.0, 49.0: 41.0   2.157        0.1419
   GGTAT                  0.462       48.0: 46.0, 37.0: 53.0   1.832        0.1759
  Block 5                                                                   
   TCAT                   0.575       55.0: 41.0, 52.0: 38.0   0.004        0.9466
   TTAA                   0.301       30.0: 66.0, 26.0: 64.0   0.123        0.7257
   CTGA                   0.108       8.0: 88.0, 12.0: 78.0    1.210        0.2713
  Block 6                                                                   
   AACCTC                 0.291       34.6: 61.4, 19.5: 70.5   4.656        0.0309[\*](#tfn1-medscimonit-25-1439){ref-type="table-fn"}
   AGCGTC                 0.289       19.3: 76.7, 34.5: 55.5   7.444        0.0064[\*\*](#tfn2-medscimonit-25-1439){ref-type="table-fn"}
   GGCGCT                 0.237       22.0: 74.0, 22.0: 68.0   0.060        0.8064
   GGTGCC                 0.134       14.0: 82.0, 11.0: 79.0   0.222        0.6373
  Block 7                                                                   
   GG                     0.474       38.9: 57.1, 49.3: 40.7   3.753        0.0527
   CA                     0.424       45.9: 50.1, 33.0: 57.0   2.378        0.1231
  Block 8                                                                   
   GGCCT                  0.756       79.0: 17.0, 61.5: 28.5   4.864        0.0274[\*](#tfn1-medscimonit-25-1439){ref-type="table-fn"}

P\<0.05,

P\<0.01.

###### 

Alleles of target SNPs and allele frequencies between GD cases and controls.

  SNPs         Genotype frequency   *P* value   Allele frequency   *P* value               
  ------------ -------------------- ----------- ------------------ ----------- ----- ----- -------
  rs7713010    CC                   CT          TT                             C     T     
  Case         141                  37          5                              319   47    
  Control      207                  63          3                  0.351       477   69    0.928
  rs12653715   GG                   GC          CC                             G     C     
  Case         97                   78          25                             272   128   
  Control      109                  132         37                 0.117       350   206   0.106
  rs12652081   TT                   CT          CC                             T     C     
  Case         61                   100         39                             222   178   
  Control      97                   144         42                 0.360       338   228   0.191
  rs6882292    GG                   GA          AA                             G     A     
  Case         168                  14          0                              350   14    
  Control      251                  21          1                  0.596       523   23    0.754
  rs1368408    GG                   GA          AA                             G     A     
  Case         144                  53          3                              341   59    
  Control      194                  78          10                 0.360       466   98    0.277
  rs3910207    CC                   CT          TT                             C     T     
  Case         152                  30          1                              334   32    
  Control      236                  41          2                  0.866       513   45    0.928
  rs3843496    CC                   CT          TT                             C     T     
  Case         116                  96          7                              328   110   
  Control      151                  113         16                 0.356       415   145   0.780
  rs3910183    TT                   TG          GG                             T     G     
  Case         167                  31          0                              365   31    
  Control      235                  43          0                  0.955       513   43    0.957
  rs2853697    AA                   AC          CC                             A     C     
  Case         108                  70          5                              286   80    
  Control      177                  85          11                 0.268       439   107   0.407

###### 

Transmission disequilibrium test for each SNPs locus in the *JAKMIP2* and *SCGB3A2* genes.

  Gene               SNPs              Over-transmitted Allele   80 pedigrees                                                 Positive linkage pedigrees                                                                  
  ------------------ ----------------- ------------------------- ------------------------------------------------------------ ---------------------------- -------------------------------------------------------------- --------
  JAKMIP2            SNP61-rs7713010   T                         26: 18                                                       0.2278                       7: 4                                                           0.3657
  SNP62-rs12653715   G                 53: 34                    0.0416[\*](#tfn4-medscimonit-25-1439){ref-type="table-fn"}   21: 9                        0.0285[\*](#tfn4-medscimonit-25-1439){ref-type="table-fn"}     
  SNP63-rs12652081   C                 63: 40                    0.0234[\*](#tfn4-medscimonit-25-1439){ref-type="table-fn"}   33: 10                       0.0005[\*\*](#tfn5-medscimonit-25-1439){ref-type="table-fn"}   
  SCGB3A2            SNP68-rs6882292   G                         10: 9                                                        0.8185                       3: 3                                                           1.0000
  SNP69-rs1368408    G                 30: 26                    0.593                                                        13: 8                        0.2752                                                         
  SNP70-rs3910207    T                 17: 16                    0.8618                                                       6: 3                         0.3173                                                         
  SNP71-rs3843496    C                 45: 36                    0.3173                                                       18: 12                       0.2733                                                         
  SNP72-rs3910183    T                 18: 15                    0.6015                                                       7: 3                         0.2059                                                         

T -- transmission; U -- non-transmission.

*P*\<0.05;

*P*\<0.01.

###### 

Transmission disequilibrium test for haplotypes in the*JAKMIP2* and *SCGB3A2* genes.

  Gene      Haplotype   Frequency    80 pedigrees   Positive linkage pedigrees                                                                                                
  --------- ----------- ------------ -------------- ------------------------------------------------------------ ------------------------------------------------------------ --------------------------------------------------------------
  JAKMIP2   CGC +TGC    0.410        63.0: 38.0     0.0128[\*](#tfn7-medscimonit-25-1439){ref-type="table-fn"}   33.0: 10.0                                                   0.0005[\*\*](#tfn8-medscimonit-25-1439){ref-type="table-fn"}
  CCT       0.372       35.4: 51.5   0.0838         10.5: 21.6                                                   0.0489[\*](#tfn7-medscimonit-25-1439){ref-type="table-fn"}   
  CGT       0.214       30.6: 36.5   0.4732         8.6: 20.5                                                    0.0282[\*](#tfn7-medscimonit-25-1439){ref-type="table-fn"}   
  SCGB3A2   GGCCT       0.740        41: 35         0.4912                                                       14.0: 11.0                                                   0.5476
  GGCTT     0.093       18: 18       1.0000         10.0: 7.0                                                    0.4643                                                       
  GACTT     0.077       8: 13        0.2754         4.0: 8.0                                                     0.2434                                                       
  GATTG     0.038       8: 7         0.7963         0.0: 3.0                                                     0.0845                                                       
  AATTG     0.036       8: 7.9       0.9754         2.0: 1.0                                                     0.3128                                                       

T -- transmission; U -- non-transmission.

*P*\<0.05;

*P*\<0.01.
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